News, Events & Careers

MR Solutions: New partner for Phase II and III of the IMAPPI project

IMAPPI_MRSMR Solutions, partner of the Integrated Magnetic resonance and Positron emission tomography in Preclinical Imaging (IMAPPI) consortium, takes over the completion of phase 2 for sequential PET/MR imager and phase 3 for simultaneous PET/MR imager (installed at the Georges-François Leclerc center in Dijon, France).

MR Solutions, the pioneer and the leading supplier of cryogen-free superconducting MRI up to 7.0T, has been selected by the IMAPPI consortium to replace the previous selected partner and complete the IMAPPI project. The IMAPPI project is supported by a French Government grant managed by the French National Research Agency (ANR) under the program “Investissements d’Avenir” (with reference ANR- 10-EQPX-05-01/IMAPPI Equipex).

MR Solutions installed phase 2 of the IMAPPI project In March 2016. This phase consisted of an in-line PET module with a high-field MRI system. The data is acquired sequentially and co-registered automatically.

The final phase of the project, phase 3, will consist of a large bore, high-field MRI with a PET module inserted in the field of view of the MRI. This will allow simultaneous acquisition of PET and MR data.

The simultaneous PET/MR system will be installed by fall of 2016. Both phase 2 and phase 3 systems are designed for preclinical imaging.

MR Solutions is one of the most innovative companies in Magnetic Resonance Imaging over the recent years, and today with PET modules, MR Solutions can demonstrate its full capabilities in multi-modality imaging.

Dr François Brunotte, Project Coordinator and Professor of Nuclear Medicine says, “We truly believe that multi-parametric and quantitative images from the IMAPPI PET/MR system, will bring crucial advantages in oncology and cardiovascular research, due to its high soft tissue contrast and high-resolution. Besides the expertise brought by MR Solutions, the project takes advantage from the close presence of hospitals, labs and facilities in various fields such as; physics, chemistry, biology, medical imaging, etc. The installation of the imaging system in the department of Nuclear Medicine at the Centre Georges-François Leclerc-CGFL, which specializes in oncology, makes for an easy and efficient translation from the bench to the clinic.”

Dr David Taylor, Chairman and CEO of MR Solutions, Ltd explains: “We are extremely delighted to be the company that will complete the IMAPPI project. Only a company with strong expertise in MRI, such as MR Solutions, can achieve the integration of a PET scanner with a high-field MR system. MR Solutions has been investing massively in the multi-modality area with an innovative approach and we are pleased to become the key player in the IMAPPI project.”

Since the IMAPPI project has started, MR Solutions has been a reliable partner. The company has demonstrated strong means and the capabilities needed to achieve Phase 3 smoothly” states Mr Jean-Jacques Wawrzyniak, Directeur General of the Fondation de Cooperation Scientifique (FCS) Bourgogne Franche-comté, the coordinating IMAPPI project partner.

Fabrice Chaumard, VP Sales and Marketing at MR Solutions, adds “As one of the initiators of the IMAPPI project, I’m glad to have MR Solutions as the leading partner and to work in close collaboration with all the partners in Dijon again. This project, binding two modalities, PET and high-field MRI generates huge interest in the research community who looks at translational imaging from the lab to the clinic. MR Solutions brings its expertise not only from the preclinical but also from the clinical area”

About MR Solutions:
MR Solutions, Guildford, Surrey, UK, has over 30 years’ experience and in excess of 1000 installations across the world. Its scanners are renowned for their excellence in terms of superior soft tissue contrast and molecular imaging ability. Operating out of offices in the UK, USA and with distributors in all the major markets, maintenance and service coverage is offered across the globe.

MR Solutions has its global headquarters at Ashbourne House, The Guildway, Old Portsmouth Road, Guildford, Surrey GU3 1LR

Fabrice Chaumard
tel: + 44 1483 532146